Skip to main content
Swing Capital

Anuh Pharma Ltd

NSE: ANUHPHR BSE: 506260Pharma

Incorporated in 1960, Anuh Pharma Ltd is in the business of manufacturing and selling of Bulk drugs and chemicals[1]

₹77.6
52W: ₹66.7 — ₹115
PE 18.6 · Book ₹32.6 · +138% vs book
Market Cap₹778 Cr
Stock P/E18.6Price to Earnings
ROCE17.2%Return on Capital
ROE13.4%Return on Equity
Div. Yield1.93%Face Value ₹5

Strengths

  • +Company has reduced debt.
  • +Company is almost debt free.
  • +Company has been maintaining a healthy dividend payout of 21.5%

Shareholding Pattern

Promoters71.79%
FIIs0.05%
DIIs0%
Public28.14%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters69.91%69.91%69.91%69.91%69.91%71.81%▲1.971.81%71.79%▼0.0
FIIs0.03%0.02%▼0.00.02%0.04%▲0.00.04%0%▼0.00%0.05%▲0.1
DIIs0%0%0%0%0%0%0%0%
Public30.05%30.06%▲0.030.07%▲0.030.04%▼0.030.04%28.19%▼1.828.17%▼0.028.14%▼0.0

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales150172164138166160198186186197
Expenses132148145127149145179176174180
Operating Profit18241911171519101217
OPM %12%14%12%8%10%9%9%6%6%9%
Net Profit141915101510128813
EPS ₹1.381.911.530.951.51.031.240.830.761.34

AI Insights

Revenue Trend

TTM revenue at ₹768Cr, up 16% YoY. OPM at 8%.

Debt Position

Borrowings at ₹0Cr. Debt-to-equity ratio: 0.00x. Healthy balance sheet.

Capex Cycle

CWIP at ₹1Cr (2% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 0% (+0.00pp change). FIIs: 0.05% (+0.05pp change). Promoters hold 71.79%.

Margin & Efficiency

ROCE declining from 31% (Mar 2014) to 17% (Mar 2025). Working capital days: 68.

Valuation

PE 18.6x with 17.2% ROCE. Price is 138% above book value of ₹32.6. Dividend yield: 1.93%.

Recent Announcements